3.31
+0.06(+1.85%)
Currency In USD
| Previous Close | 3.25 |
| Open | 3.28 |
| Day High | 3.33 |
| Day Low | 3.23 |
| 52-Week High | 5.8 |
| 52-Week Low | 2.12 |
| Volume | 1.06M |
| Average Volume | 1.54M |
| Market Cap | 328.78M |
| PE | -5.71 |
| EPS | -0.58 |
| Moving Average 50 Days | 2.91 |
| Moving Average 200 Days | 3.62 |
| Change | 0.06 |
If you invested $1000 in Aquestive Therapeutics, Inc. (AQST) since IPO date, it would be worth $206.23 as of June 30, 2025 at a share price of $3.31. Whereas If you bought $1000 worth of Aquestive Therapeutics, Inc. (AQST) shares 5 years ago, it would be worth $681.07 as of June 30, 2025 at a share price of $3.31.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit
GlobeNewswire Inc.
Jun 25, 2025 11:00 AM GMT
WARREN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science a
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions
GlobeNewswire Inc.
Jun 16, 2025 11:00 AM GMT
FDA assigns PDUFA target action date of January 31, 2026 WARREN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful im
Aquestive Therapeutics to Participate in Citizens Life Sciences Conference
GlobeNewswire Inc.
May 05, 2025 11:00 AM GMT
WARREN, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science an